首页 | 官方网站   微博 | 高级检索  
     

乙肝病毒感染的恶性淋巴瘤患者化疗后肝功能变化
引用本文:吴荣. 乙肝病毒感染的恶性淋巴瘤患者化疗后肝功能变化[J]. 川北医学院学报, 2017, 32(1): 86-88. DOI: 10.3969/j.issn.1005-3697.2017.01.024
作者姓名:吴荣
作者单位:安康市人民医院感染科,陕西安康,725000
摘    要:目的:研究乙肝病毒(hepatitis B virus,HBV)感染的恶性淋巴瘤患者化疗后肝功能变化。方法:收集本院确诊HBV感染恶性淋巴瘤接受化疗患者278例,检测并比较HBV感染合并霍奇金淋巴瘤(hodgkin’s lymphoma,HL)及非霍奇金淋巴瘤(non hodgkin lymphoma,NHL)患者化疗后肝功能变化特点。结果:HBV感染的恶性淋巴瘤患者化疗后肝功能损害发生率47.8%(133/278)。HL组肝功能损害发生率37.0%,低于NHL组的54.7%(χ~2=8.263,P=0.003),HL组重度肝功能损害(Ⅲ度+Ⅳ度)率3.7%(4/108),低于NHL组的13.5%(23/170)(χ~2=7.271,P=0.005)。治疗前HBV-DNA>104copy/m L患者肝功能损害发生率42.3%(58/137),<104 copy/m L患者肝功能损害发生率53.2%(75/141),差异无统计学意义(χ~2=3.282,P=0.045);但是治疗前HBV-DNA>104 copy/m L患者重度肝功能损害发生率14.6%(20/137)高于<104 copy/m L患者重度肝功能损害发生率5.0%(7/141)(χ~2=7.355,P=0.006)。结论:恶性淋巴瘤合并乙肝病毒感染化疗后肝功能损害明显,NHL患者更易感染,临床诊疗时需注意监测并及时处理。

关 键 词:恶性淋巴瘤  乙肝病毒  化疗  肝功能损害

Changes of liver function in patients of malignant lymphoma with hepatitis B virus infection after chemotherapy
WU Rong. Changes of liver function in patients of malignant lymphoma with hepatitis B virus infection after chemotherapy[J]. Journal of North Sichuan Medical College, 2017, 32(1): 86-88. DOI: 10.3969/j.issn.1005-3697.2017.01.024
Authors:WU Rong
Abstract:Objective:Changes of liver function in patients of malignant lymphoma with hepatitis B virus (HBV) infection after chemotherapy.Methods:278 cases of patients of malignant lymphoma with HBV infection receiving chemotherapy in our hospital were collected,the changes of liver function in patients with hepatitis B virus infection combined with Hodgkin's lymphoma (HL) and non Hodgkin lymphoma (NHL) were detected and compared.Results:The incidence of liver damage in patients with hepatitis B virus infection after chemotherapy was 47.8% (133/278).The incidence of liver function damage in HL group was 37%,was less than 54.7% in group NHL (x2=8.263,P =0.003),The rate of severe liver damage in HL group was 3.7% (4/108),was less than 13.5% in group NHL (23/170)(x2 =7.271,P =0.005).The incidence of liver damage in patients with HBV-DNA > 104 copy/mL before treatment was 42.3% (58/137),and the incidence of liver damage in patients with < 104 copy/mL was 53.2% (75/141),There was no statistically significant difference (x2 =3.282,P =0.045);But the incidence rate of severe liver function damage in patients with HBV-DNA > 104copy/mL before treatment was14.6% (20/137),higher than incidence rate of severe liver function in patients with damage < 104 copy/mL (5.0%,7/141) (x2 =7.355,P =0.006).Conclusions:The liver function damage in patients with malignant lymphoma complicated with hepatitis B virus infection is obvious,NHL patients more susceptible,Attention should be paid to monitoring and timely treatment in clinical diagnosis.
Keywords:Malignant lymphoma  Hepatitis B virus  Chemotherapy  Liver function damage
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号